ASTH
Price
$38.89
Change
-$0.16 (-0.41%)
Updated
May 10, 6:59 PM EST
82 days until earnings call
SGRY
Price
$26.59
Change
-$0.50 (-1.85%)
Updated
May 10, 6:59 PM EST
80 days until earnings call
Ad is loading...

ASTH vs SGRY

Header iconASTH vs SGRY Comparison
Open Charts ASTH vs SGRYBanner chart's image
Astrana Health
Price$38.89
Change-$0.16 (-0.41%)
Volume$71.96K
CapitalizationN/A
Surgery Partners
Price$26.59
Change-$0.50 (-1.85%)
Volume$674.83K
CapitalizationN/A
View a ticker or compare two or three
ASTH vs SGRY Comparison Chart

Loading...

ASTHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SGRYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ASTH vs. SGRY commentary
May 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a StrongSell and SGRY is a Hold.

COMPARISON
Comparison
May 12, 2024
Stock price -- (ASTH: $38.89 vs. SGRY: $26.59)
Brand notoriety: ASTH and SGRY are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ASTH: 112% vs. SGRY: 115%
Market capitalization -- ASTH: $1.88B vs. SGRY: $3.66B
ASTH [@Medical/Nursing Services] is valued at $1.88B. SGRY’s [@Medical/Nursing Services] market capitalization is $3.66B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 0 FA rating(s) are green whileSGRY’s FA Score has 0 green FA rating(s).

  • ASTH’s FA Score: 0 green, 5 red.
  • SGRY’s FA Score: 0 green, 5 red.
According to our system of comparison, ASTH is a better buy in the long-term than SGRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 4 TA indicator(s) are bullish while SGRY’s TA Score has 4 bullish TA indicator(s).

  • ASTH’s TA Score: 4 bullish, 6 bearish.
  • SGRY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SGRY is a better buy in the short-term than ASTH.

Price Growth

ASTH (@Medical/Nursing Services) experienced а +3.82% price change this week, while SGRY (@Medical/Nursing Services) price change was +8.40% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.81%. For the same industry, the average monthly price growth was +1.26%, and the average quarterly price growth was +11.25%.

Reported Earning Dates

ASTH is expected to report earnings on Aug 01, 2024.

SGRY is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Medical/Nursing Services (+0.81% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ASTH with price predictions.
OPEN
A.I.dvisor published
a Summary for SGRY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SGRY($3.66B) has a higher market cap than ASTH($1.88B). ASTH YTD gains are higher at: 1.540 vs. SGRY (-16.880). SGRY has higher annual earnings (EBITDA): 446M vs. ASTH (124M). ASTH has more cash in the bank: 296M vs. SGRY (196M). ASTH has less debt than SGRY: ASTH (321M) vs SGRY (3.06B). SGRY has higher revenues than ASTH: SGRY (2.74B) vs ASTH (1.39B).
ASTHSGRYASTH / SGRY
Capitalization1.88B3.66B52%
EBITDA124M446M28%
Gain YTD1.540-16.880-9%
P/E Ratio32.55N/A-
Revenue1.39B2.74B51%
Total Cash296M196M151%
Total Debt321M3.06B10%
FUNDAMENTALS RATINGS
ASTH vs SGRY: Fundamental Ratings
ASTH
SGRY
OUTLOOK RATING
1..100
513
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
7361
SMR RATING
1..100
7090
PRICE GROWTH RATING
1..100
5062
P/E GROWTH RATING
1..100
8359
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASTH's Valuation (67) in the null industry is somewhat better than the same rating for SGRY (100) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew somewhat faster than SGRY’s over the last 12 months.

SGRY's Profit vs Risk Rating (61) in the Hospital Or Nursing Management industry is in the same range as ASTH (73) in the null industry. This means that SGRY’s stock grew similarly to ASTH’s over the last 12 months.

ASTH's SMR Rating (70) in the null industry is in the same range as SGRY (90) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to SGRY’s over the last 12 months.

ASTH's Price Growth Rating (50) in the null industry is in the same range as SGRY (62) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to SGRY’s over the last 12 months.

SGRY's P/E Growth Rating (59) in the Hospital Or Nursing Management industry is in the same range as ASTH (83) in the null industry. This means that SGRY’s stock grew similarly to ASTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHSGRY
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 17 days ago
72%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ASTHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SGRYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEMBX12.620.02
+0.16%
Putnam Emerging Markets Equity B
EURAUD1.63N/A
N/A
Euro - Australian Dollar
HKDGBP0.10N/A
N/A
Hong Kong Dollar - United Kingdom Pound
NZDJPY93.78N/A
N/A
New Zealand Dollar - Japan Yen
RMVIX26.35-0.12
-0.45%
RBC Microcap Value I

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ENSG. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ENSG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
-0.41%
ENSG - ASTH
40%
Loosely correlated
+0.54%
MD - ASTH
38%
Loosely correlated
+0.61%
SGRY - ASTH
36%
Loosely correlated
-1.85%
AGL - ASTH
35%
Loosely correlated
-1.33%
LFST - ASTH
34%
Loosely correlated
-3.65%
More

SGRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGRY has been loosely correlated with THC. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SGRY jumps, then THC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGRY
1D Price
Change %
SGRY100%
-1.85%
THC - SGRY
62%
Loosely correlated
-0.43%
HCA - SGRY
55%
Loosely correlated
+1.48%
SEM - SGRY
48%
Loosely correlated
+1.08%
UHS - SGRY
48%
Loosely correlated
+0.59%
EHC - SGRY
44%
Loosely correlated
+0.19%
More